US FDA declines Moderna flu vaccine review amid vaccine guidance rollback
CEO Stephane Bancel said the letter refusing review did not cite 'any safety or efficacy concerns'.
CEO Stephane Bancel said the letter refusing review did not cite 'any safety or efficacy concerns'.
Read the full article at:
Al Jazeera β